These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 74121)

  • 21. Effects of hydroxyurea on murine type C virus-specific DNA synthesis in newly infected cells.
    Lovinger GG; Gilden RV; Hatanaka M
    Cancer Res; 1978 Jul; 38(7):2112-7. PubMed ID: 657143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of vesicular stomatitis virus pseudotype production in the study of a temperature-sensitive murine leukemia virus.
    Breitman M; Prevec L
    Virology; 1977 Feb; 76(2):643-52. PubMed ID: 65826
    [No Abstract]   [Full Text] [Related]  

  • 23. Low-molecular-weight RNAs of Moloney murine leukemia virus: identification of the primer for RNA-directed DNA synthesis.
    Peters G; Harada F; Dahlberg JE; Panet A; Haseltine WA; Baltimore D
    J Virol; 1977 Mar; 21(3):1031-41. PubMed ID: 66325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of 2'5'-oligoadenylic acid on a mouse cell line partially resistant to interferon.
    Panet A; Czarniecki CW; Falk H; Friedman RM
    Virology; 1981 Oct; 114(2):567-72. PubMed ID: 6170160
    [No Abstract]   [Full Text] [Related]  

  • 25. Decay of Moloney leukemia virus production after enucleation of chronically infected mouse cells.
    Ber R; Fenyo EM; Nexø BA; Skoog L
    Isr J Med Sci; 1981 Aug; 17(8):690-6. PubMed ID: 6169684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro synthesis of infectious DNA of murine leukaemia virus.
    Rothenberg E; Smotkin D; Baltimore D; Weinberg RA
    Nature; 1977 Sep; 269(5624):122-6. PubMed ID: 71657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective inhibition by kanamycin of focus formation by Rous and Moloney sarcoma viruses.
    Murphy WH; Maisel J; Bullis C; Faras AJ
    J Natl Cancer Inst; 1974 May; 52(5):1463-8. PubMed ID: 4133953
    [No Abstract]   [Full Text] [Related]  

  • 28. The virus-specific RNA species in free and membrane-bound polyribosomes of transformed cells replicating murine sarcoma-leukemia viruses.
    Shanmugam G; Bhaduri S; Green M
    Biochem Biophys Res Commun; 1974 Feb; 56(3):697-702. PubMed ID: 4133215
    [No Abstract]   [Full Text] [Related]  

  • 29. Release of C-type particles from normal rat thymus cultures and those infected with Moloney leukemia virus.
    Teitz Y; Lennette EH; Oshiro LS; Cremer NE
    J Natl Cancer Inst; 1971 Jan; 46(1):11-23. PubMed ID: 4251036
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis of a 600-nucleotide-long plus-strand DNA by virions of Moloney murine leukemia virus.
    Mitra SW; Goff S; Gilboa E; Baltimore D
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4355-9. PubMed ID: 92028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of reverse-transcriptase in interferon-treated mouse cells chronically infected with Moloney leukemia virus.
    Sherman L; Eylan E; Teitz Y
    Arch Virol; 1980; 66(2):143-55. PubMed ID: 6159872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of interferon on murine leukaemia virus infection. IV. Formation of non-infectious virus in chronically infected cells.
    Pitha PM; Wivel NA; Fernie BF; Harper HP
    J Gen Virol; 1979 Mar; 42(3):467-80. PubMed ID: 85689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiestrogens inhibit the replication of the retroviral Moloney murine leukemia virus in vitro.
    Chailleux C; Mesange F; Bayard F; Prats AC; Faye JC
    Mol Pharmacol; 1993 Aug; 44(2):324-7. PubMed ID: 7689144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycoprotein enrichment in Moloney leukemia virus structural proteins released from interferon-treated cells.
    Sherman L; Teitz Y
    Exp Cell Biol; 1981; 49(4):185-94. PubMed ID: 6166504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon inhibits induction of endogenous murine leukemia virus production.
    Ramseur JM; Friedman RM
    Virology; 1976 Sep; 73(2):553-6. PubMed ID: 183371
    [No Abstract]   [Full Text] [Related]  

  • 36. In vitro studies of the replication of Moloney murine leukemia virus.
    Haseltine WA; Coffin JM
    Cold Spring Harb Symp Quant Biol; 1979; 43 Pt 2():841-9. PubMed ID: 90575
    [No Abstract]   [Full Text] [Related]  

  • 37. Mutations of the RNase H C helix of the Moloney murine leukemia virus reverse transcriptase reveal defects in polypurine tract recognition.
    Lim D; Orlova M; Goff SP
    J Virol; 2002 Aug; 76(16):8360-73. PubMed ID: 12134040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the synthesis of Moloney leukemia virus structural proteins by N-methylisatin-beta-4',4'-diethylthiosemicarbazone.
    Ronen D; Teitz Y
    Antimicrob Agents Chemother; 1984 Dec; 26(6):913-6. PubMed ID: 6084472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematoporphyrin-sensitized photodynamic inactivation of viral RNA-dependent DNA polymerase.
    Munson BR; Fiel RJ
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):175-8. PubMed ID: 65786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of interferon on murine leukemia virus infection. II. Synthesis of viral components in exogenous infection.
    Pitha PM; Staal SP; Bolognesi DP; Denny TP; Rowe WP
    Virology; 1977 Jun; 79(1):1-13. PubMed ID: 194399
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.